Is endoscopic sleeve gastroplasty safe? Common side effects that settle, uncommon complications to know, who should not have ESG, and how risk is reduced. By YOUNIFY's medical team.
Contents
Key Takeaways
- ESG is less invasive than surgery, with no external incisions and no stomach tissue removed, but it is not a risk-free procedure — it should be performed under the care of a medical team and only after a proper suitability assessment.
- The most common side effects are nausea, vomiting, and dull or cramping abdominal discomfort in the first 1–3 days, which generally improve over time; recovery is typically about 1–3 days, while the dietary adjustment phase is longer.
- Medical evidence indicates that serious complications are uncommon — but "uncommon" is not "never." Safety depends on the pre-procedure assessment, the medical team and facility standards, and structured follow-up afterward.
How does ESG differ from sleeve surgery, and why is the risk profile different?
Is ESG safe is the question patients ask most often after price — and it is the right question, because every procedure carries risk and no approach is entirely free of side effects. In this guide, YOUNIFY's medical team explains plainly how endoscopic sleeve gastroplasty differs from surgery, which side effects are common and usually settle on their own, which complications are uncommon but worth knowing, who should not have ESG, the warning signs that need urgent review, and how risk is reduced through careful assessment and structured follow-up. If you are new to the procedure, start with our main guide, ESG: endoscopic sleeve gastroplasty for non-surgical weight loss.
The key differences are the route of access and what is done to the stomach. Sleeve gastrectomy is performed through the abdomen, leaves external incisions, and permanently removes part of the stomach. ESG is performed through the mouth with an endoscope, leaves no external incisions, and folds and sutures the stomach wall from the inside without removing tissue.
That changes the shape of the risk. Risks tied to abdominal surgery — wound infection, incisional hernia, or a surgical staple-line leak — are not the principal risks of ESG. But ESG carries its own: risks related to endoscopy and sedation, and the adjustment symptoms of a stomach that has just been reshaped.
To be clear: ESG is less invasive than surgery, but it is not a risk-free procedure. It should be performed under the care of a medical team, in a facility with monitoring equipment and an escalation pathway, and only after a proper suitability assessment.
Common side effects that usually settle on their own
In the first days after the procedure, the stomach is adapting to its new shape. The following are anticipated by the medical team and generally improve over time:
- Nausea and vomiting — the most common effects in the first 1–3 days, often related to adjustment and drinking too quickly. The medical team provides appropriate symptom relief.
- Dull or cramping pain in the upper abdomen — from the sutured stomach contracting in its new shape; usually eases within a few days.
- Fullness and feeling full unusually fast — this is the intended effect of the procedure, but it can feel stronger than expected at first, so portions are increased gradually as advised.
- Reflux or heartburn — occurs in some patients; acid-reducing medication is commonly given early on and adjusted according to symptoms.
- Sore throat or mild hoarseness — from passing the endoscope through the mouth; usually resolves in a day or two.
- Fatigue — from reduced food and fluid intake during the transition, which is why sipping fluids according to plan matters.
Most patients recover quickly and go home the same day or after a short observation period, with typically about 1–3 days of recovery. The dietary adjustment phase is longer than that and is managed through follow-up.
Uncommon complications you should know about before deciding
Systematic reviews and randomised trial data indicate that serious complications after ESG are uncommon — but "uncommon" is not "never." Before consenting, you should know about:
- Gastrointestinal bleeding — from a suture site; most cases are minor and settle on their own, though some require a repeat endoscopy to manage.
- Perforation of the stomach wall — very rare, but requires immediate management, and is the main reason this procedure belongs in a facility with a clear escalation pathway.
- Perigastric fluid collection or abscess — uncommon; usually presents with fever and worsening abdominal pain, and needs further investigation and treatment.
- Sedation-related events — such as aspiration, breathing difficulty, or a reaction to medication, which is why a dedicated sedation team and continuous monitoring are used throughout.
- Persistent nausea and vomiting leading to dehydration — some patients need to return for intravenous fluids or a medication adjustment.
- Loosening of sutures over time — in some patients the plication can loosen, reducing the effect; repeating the procedure or revising the care plan may then be considered.
- Less weight loss than hoped, or weight regain — not a physical complication, but an outcome risk that deserves to be stated openly, because results depend on behaviour change as well.
At YOUNIFY, the medical team goes through these risks openly before the procedure day, along with the plan should any of them occur — because a good decision needs both sides of the picture.
Who should not have ESG (contraindications and cautions)
Suitability is decided individually after assessment. The following groups are usually not suitable, or need another condition treated first:
- An untreated stomach ulcer or active inflammation — needs treating first, which is exactly why a diagnostic gastroscopy is done beforehand.
- A bleeding disorder, or taking anticoagulant medication — requires assessment and a medication plan agreed with your existing doctor.
- Previous stomach surgery — altered anatomy can make endoscopic suturing more difficult or unsuitable.
- A large hiatal hernia or severe reflux — assessed case by case, as symptoms may worsen afterward.
- Pregnancy, or planning pregnancy in the near term — better postponed.
- Uncontrolled infection or unstable underlying disease — for example unstable cardiac or respiratory conditions, which raise sedation risk.
- An untreated eating disorder — psychological and behavioural care should come first.
- Someone not able to attend follow-up — not a medical contraindication, but it weakens both safety and results.
Warning signs that need urgent medical review
After you go home, contact the medical team immediately — do not wait and watch — if you experience:
- Severe or progressively worsening abdominal pain rather than gradual improvement
- Fever or chills
- Vomiting blood, or vomit resembling coffee grounds
- Black, tarry stools
- Vomiting that will not stop, so you cannot keep fluids down; reduced urine output; dizziness (signs of dehydration)
- Chest pain, difficulty breathing, or an unusually fast heartbeat
- Worsening difficulty swallowing, to the point you cannot take liquids
Everyone who has ESG at YOUNIFY is given a direct contact route to the medical team and these instructions in writing before discharge.
How risk is reduced
Safety in ESG does not rest on the procedure alone; it rests on three connected phases.
1) A thorough pre-procedure assessment — history and examination, blood and metabolic tests, a review of current medication (particularly anticoagulants), and a diagnostic gastroscopy to screen out ulcers, inflammation, or anatomical variations. This is the single most important risk-reduction step.
2) Team and facility during the procedure — performed under the care of the medical team with a dedicated sedation team and continuous vital-sign monitoring, using techniques and equipment that meet recognized international standards, with an escalation pathway if needed.
3) Structured follow-up — a staged eating plan (liquids to soft foods to appropriately sized regular meals), scheduled reviews through the first year, nutrition support, and a contact route for unusual symptoms. Follow-up is not only about weight outcomes; it is the mechanism that catches problems early.
What you can do — give a complete medication and medical history, follow fasting instructions strictly, stick to the post-procedure eating plan, sip fluids consistently, avoid eating quickly or beyond the advised amount in the early phase, and attend every follow-up appointment.
If you are weighing up cost alongside safety, read ESG cost in Bangkok: what's included and is it worth it.
Frequently Asked Questions
Is ESG safe?
ESG is less invasive than surgery, with no external incisions and no stomach tissue removed. Medical evidence indicates that serious complications are uncommon, but every procedure carries risk. Safety depends on the pre-procedure assessment, the medical team and facility standards, and structured follow-up afterward.
What are the most common side effects?
Nausea, vomiting, and dull or cramping abdominal discomfort in the first 1–3 days, which generally improve over time. The medical team provides symptom relief and dietary guidance as appropriate.
How long do side effects last?
Most early symptoms settle within a few days, with typically about 1–3 days of recovery. The dietary adjustment phase is longer and is managed through scheduled follow-up. This varies by individual.
Can ESG be reversed if there is a problem?
ESG removes no stomach tissue, so in many cases it can be adjusted or revised later — unlike surgery, which is a permanent change. The right approach is decided individually by the medical team.
Does everyone need a gastroscopy first?
Generally the medical team performs a diagnostic gastroscopy first, to screen for ulcers, inflammation, or anatomical variations that would make the procedure unsuitable.
Will I need ongoing medication or supplements?
Acid-reducing and symptom-relief medication is common early on. Vitamin or protein supplementation depends on the medical team's assessment and your individual nutrition plan.
Can I have ESG if I have a chronic condition?
It depends on the condition and how stable it is. Patients with unstable disease, a bleeding disorder, or who take anticoagulant medication need assessment and a plan agreed with their existing doctor first.
References
- Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial (The Lancet, 2022;400(10350):441–451 (Abu Dayyeh BK, et al.))
- Efficacy and safety of endoscopic sleeve gastroplasty: a systematic review and meta-analysis (Clinical Gastroenterology and Hepatology, 2020;18(5):1043–1053.e4 (Hedjoudje A, et al.))
- Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients (Gastrointestinal Endoscopy, 2019;89(6):1132–1138 (Alqahtani A, et al.))
- Five-year outcomes of endoscopic sleeve gastroplasty for the treatment of obesity (Clinical Gastroenterology and Hepatology, 2021;19(5):1051–1057.e2 (Sharaiha RZ, et al.))
- American Society for Gastrointestinal Endoscopy–European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity (Gastrointestinal Endoscopy, 2024;99(6):867–885 (ASGE–ESGE))
- Semaglutide vs endoscopic sleeve gastroplasty for weight loss (JAMA Network Open, 2024;7(4):e246221 (Haseeb M, et al.))
Medical Note
This article is for general information and does not replace medical examination, diagnosis, or treatment. If symptoms are severe, changing quickly, or urgent, seek medical care promptly.
Individual results may vary. Please consult a doctor before treatment.
Want to know which care plan fits you?
Share your symptoms, health history, medications or prior procedures, and personal goals. Our team can help arrange a medical assessment.
Consult YOUNIFY Clinic